ArticlePeerJ2026
Assessing COVID-19 vaccine hesitancy in Malaysian pregnant women: prevalence and influencing factors.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The World Health Organization has highlighted vaccine hesitancy as one of the top ten threats to global health, and the recent COVID-19 pandemic has demonstrated the importance of vaccination as one of the successful preventive measures, especially for high-risk groups, including pregnant women. This study aims to determine the prevalence of COVID-19 vaccine hesitancy and its influencing factors among pregnant women in Malaysia. Methods: This cross-sectional study was conducted from June 2024 to December 2024. among pregnant women at an antenatal clinic in Malaysia. Participants were selected using a non-proportionate stratified multistage cluster random sampling. The vaccine hesitancy status is measured by the Pregnancy Vaccine Hesitancy Scale (pVHS). Data were collected using a self-administered questionnaire, available through Google Forms or in printed form. Results: A total of 595 pregnant women participated (response rate: 99.2%). The prevalence of COVID-19 vaccine hesitancy was 42.5%. Vaccine hesitancy was significantly associated with incomplete or non-receipt of COVID-19 vaccination ( Conclusion: These findings underscore the importance of targeted communication strategies in addressing vaccine hesitancy among pregnant women. Moreover, involving healthcare providers in disseminating accurate information and addressing patients' concerns can be crucial in increasing vaccine acceptance among pregnant women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.